Pien Huang
Pien Huang is a health reporter on the Science desk. She was NPR's first Reflect America Fellow, working with shows, desks and podcasts to bring more diverse voices to air and online.
She's a former producer for WBUR/NPR's On Point and was a 2018 Environmental Reporting Fellow with The GroundTruth Project at WCAI in Cape Cod, covering the human impact on climate change. As a freelance audio and digital reporter, Huang's stories on the environment, arts and culture have been featured on NPR, the BBC and PRI's The World.
Huang's experiences span categories and continents. She was executive producer of Data Made to Matter, a podcast from the MIT Sloan School of Management, and was also an adjunct instructor in podcasting and audio journalism at Northeastern University. She worked as a project manager for public artist Ralph Helmick to help plan and execute The Founder's Memorial in Abu Dhabi and with Stoltze Design to tell visual stories through graphic design. Huang has traveled with scientists looking for signs of environmental change in Cameroon's frogs, in Panama's plants and in the ocean water off the ice edge of Antarctica. She has a degree in environmental science and public policy from Harvard.
-
PFAS chemicals have been used for decades to waterproof and stain-proof consumer products and are linked to health problems. -
The rate at which women in the U.S. are dying from pregnancy related causes more than doubled in recent decades. A new study, published in JAMA shows Black women and Native Americans are most at risk. -
Health officials say more vaccination, testing and awareness among people at high risk for infection with mpox could curb a potential resurgence in the U.S. -
Early fears of an escalating outbreak have not come to pass. Scientists are finding that the virus needs a very particular set of circumstances to spread effectively. -
Dr. Demetre Daskalakis is steering the U.S. monkeypox response. A month into the job, he sees signs of success, but there's still more to be done. -
Pfizer has submitted data on its bivalent COVID-19 booster shot that specifically targets the latest omicron subvariants. If authorized, the company says the shots could be ready as soon as September. -
Missteps and delays have hampered the U.S. effort to vaccinate people against monkeypox. Now state health officials and community members are trying to adapt to a controversial "dose sparing" plan. -
Recent rule changes made it easier for patients to get abortion pills through the mail, using telehealth services. Now there is growing demand for these services – and new legal battles brewing. -
Some people have had trouble getting Paxlovid pills quickly, despite the administration's effort to ease access after a COVID test confirms infection. -
A federal judge's decision to strike down the Centers for Disease Control and Prevention's mask mandate for travelers is only the latest in a series of challenges that seek to rein in the agency.
